Interplay of Carbonic Anhydrase IX With Amino Acid and Acid/Base Transporters in the Hypoxic Tumor Microenvironment.

amino acid transport carbonic anhydrase IX hypoxia tumor metabolism tumor microenvironment

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2020
Historique:
received: 04 09 2020
accepted: 09 10 2020
entrez: 26 11 2020
pubmed: 27 11 2020
medline: 27 11 2020
Statut: epublish

Résumé

Solid tumors are challenged with a hypoxic and nutrient-deprived microenvironment. Hence, hypoxic tumor cells coordinatively increase the expression of nutrient transporters and pH regulators to adapt and meet their bioenergetic and biosynthetic demands. Carbonic Anhydrase IX (CAIX) is a membrane-bound enzyme that plays a vital role in pH regulation in the tumor microenvironment (TME). Numerous studies have established the importance of CAIX in mediating tumor progression and metastasis. To understand the mechanism of CAIX in mediating tumor progression, we performed an unbiased proteomic screen to identify the potential interactors of CAIX in the TME using the proximity-dependent biotin identification (BioID) technique. In this review, we focus on the interactors from this BioID screen that are crucial for nutrient and metabolite transport in the TME. We discuss the role of transport metabolon comprising CAIX and bicarbonate transporters in regulating intra- and extracellular pH of the tumor. We also discuss the role of amino acid transporters that are high confidence interactors of CAIX, in optimizing favorable metabolic state for tumor progression, and give our perspective on the coordinative interplay of CAIX with the amino acid transporters in the hypoxic TME.

Identifiants

pubmed: 33240897
doi: 10.3389/fcell.2020.602668
pmc: PMC7680889
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

602668

Informations de copyright

Copyright © 2020 Venkateswaran and Dedhar.

Références

Nature. 2011 Nov 20;481(7381):380-4
pubmed: 22101433
Nat Rev Cancer. 2017 Oct;17(10):577-593
pubmed: 28912578
Sci Rep. 2014 Mar 19;4:4410
pubmed: 24642931
Int J Cancer. 2016 Dec 1;139(11):2529-39
pubmed: 27486861
Am J Physiol Cell Physiol. 2001 Oct;281(4):C1077-93
pubmed: 11546643
Oncotarget. 2012 Jan;3(1):84-97
pubmed: 22289741
J Biol Chem. 2009 Jul 24;284(30):20299-310
pubmed: 19458084
Endocr Relat Cancer. 2006 Sep;13(3):921-30
pubmed: 16954440
Cancer Immunol Res. 2019 Jul;7(7):1064-1078
pubmed: 31088846
Front Cell Dev Biol. 2020 Jul 17;8:651
pubmed: 32766253
Nat Commun. 2017 Jul 03;8:15965
pubmed: 28671190
Front Cell Dev Biol. 2020 Jul 08;8:603
pubmed: 32733894
Cell. 2016 Jun 30;166(1):126-39
pubmed: 27368101
Oncogene. 2016 Jun 16;35(24):3201-8
pubmed: 26455325
J Clin Oncol. 2001 Aug 15;19(16):3660-8
pubmed: 11504747
J Med Chem. 2012 Jun 14;55(11):5591-600
pubmed: 22621623
Chem Rev. 2012 Aug 8;112(8):4421-68
pubmed: 22607219
J Med Chem. 2011 Mar 24;54(6):1896-902
pubmed: 21361354
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12079-84
pubmed: 10518579
Int J Mol Sci. 2020 Jun 16;21(12):
pubmed: 32560271
Int J Mol Sci. 2019 Jun 04;20(11):
pubmed: 31167468
Oncogenesis. 2017 Jul 31;6(7):e367
pubmed: 28759021
Am J Transl Res. 2015 Jun 15;7(6):1161-71
pubmed: 26279759
J Biol Chem. 2017 Oct 13;292(41):16825-16832
pubmed: 28842498
Cancer Cell. 2015 Mar 9;27(3):354-69
pubmed: 25759021
Nat Struct Mol Biol. 2018 Jun;25(6):515-521
pubmed: 29872227
Int J Cancer. 2014 Sep 1;135(5):1060-71
pubmed: 24531984
Cancer Cell. 2012 Mar 20;21(3):297-308
pubmed: 22439925
Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):355-60
pubmed: 15625115
Cell Stem Cell. 2014 Aug 7;15(2):169-84
pubmed: 24953180
Nat Rev Clin Oncol. 2017 Jan;14(1):11-31
pubmed: 27141887
Oncotarget. 2017 Sep 12;8(44):77819-77835
pubmed: 29100428
J Biol Chem. 2016 Jun 17;291(25):13194-205
pubmed: 27129276
Cancer Discov. 2020 Jul;10(7):1018-1037
pubmed: 32341021
J Biol Chem. 2001 Mar 23;276(12):8746-52
pubmed: 11121428
J Biol Chem. 2007 Jul 6;282(27):19788-98
pubmed: 17488712
Nat Cell Biol. 2019 Nov;21(11):1425-1435
pubmed: 31685994
Metabolites. 2018 Feb 28;8(1):
pubmed: 29495652
Pharmacol Ther. 2009 Jan;121(1):29-40
pubmed: 18992769
Cell Cycle. 2018;17(9):1056-1067
pubmed: 29895196
Cancers (Basel). 2020 Apr 07;12(4):
pubmed: 32272695
Cancer. 2009 Apr 1;115(7):1448-58
pubmed: 19195047
Nat Med. 2018 Feb;24(2):194-202
pubmed: 29334372
Br J Cancer. 2009 Mar 24;100(6):874-80
pubmed: 19240720
Cancer Res. 2009 Jan 1;69(1):358-68
pubmed: 19118021
Nat Commun. 2019 Jan 14;10(1):201
pubmed: 30643150
Cancer Res. 2014 Oct 1;74(19):5507-19
pubmed: 25085245
JCI Insight. 2017 Dec 21;2(24):
pubmed: 29263302
PLoS One. 2016 Dec 30;11(12):e0168907
pubmed: 28036362
Pflugers Arch. 2004 Feb;447(5):784-95
pubmed: 12845534
Clin Cancer Res. 2012 Jun 1;18(11):3100-11
pubmed: 22498007
J Cancer Res Clin Oncol. 2018 May;144(5):821-833
pubmed: 29435734
Cancer Res. 2015 Mar 15;75(6):996-1008
pubmed: 25623234
Br J Cancer. 2010 May 25;102(11):1627-35
pubmed: 20461082
Front Physiol. 2013 Oct 10;4:291
pubmed: 24133456
Biochem J. 2006 May 1;395(3):517-27
pubmed: 16445384
Cell Signal. 2014 Aug;26(8):1668-79
pubmed: 24726839
Biochem J. 2006 Jul 15;397(2):369-75
pubmed: 16629640
Nat Rev Drug Discov. 2011 Sep 16;10(10):767-77
pubmed: 21921921
J Biol Chem. 2019 Mar 15;294(11):4012-4026
pubmed: 30635397
Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):15-22
pubmed: 30006019
Trends Biochem Sci. 2010 Aug;35(8):427-33
pubmed: 20570523
Oncotarget. 2018 Jun 15;9(46):27940-27957
pubmed: 29963253
Cell. 2009 Feb 6;136(3):521-34
pubmed: 19203585
Br J Cancer. 2014 Apr 15;110(8):2030-9
pubmed: 24603303
Cancers (Basel). 2020 Jul 22;12(8):
pubmed: 32707920
Subcell Biochem. 2014;75:255-69
pubmed: 24146383
Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E603-13
pubmed: 19158318
Nat Genet. 2009 May;41(5):585-90
pubmed: 19330027
Int J Cancer. 2013 Mar 15;132(6):1288-99
pubmed: 22907202
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16233-8
pubmed: 19805286
Biochim Biophys Acta. 2016 Aug;1866(1):76-86
pubmed: 27343712
J Biol Chem. 2014 Jan 31;289(5):2765-75
pubmed: 24338019
J Biol Chem. 1998 Sep 11;273(37):23629-32
pubmed: 9726963
Immunity. 2014 May 15;40(5):692-705
pubmed: 24792914
Histopathology. 2015 Jan;66(2):234-43
pubmed: 24845232
Sci Rep. 2015 Sep 04;5:13605
pubmed: 26337752
Gastroenterology. 2019 Sep;157(3):823-837
pubmed: 31078621
J Pathol. 2015 Jan;235(1):90-100
pubmed: 25142020
J Pathol. 2015 Jul;236(3):278-89
pubmed: 25693838
Oncogene. 2016 Apr 21;35(16):2112-22
pubmed: 26212013
Mol Cell. 2015 Nov 19;60(4):514-23
pubmed: 26590711
Cancer Res. 2011 May 1;71(9):3364-76
pubmed: 21415165
Biochim Biophys Acta Biomembr. 2018 Jul;1860(7):1460-1469
pubmed: 29678469
Oncogene. 2017 Nov 9;36(45):6244-6261
pubmed: 28692057
Int J Mol Sci. 2017 Jul 27;18(8):
pubmed: 28749408
J Cell Biol. 2012 Mar 19;196(6):801-10
pubmed: 22412018
Pharmacol Res. 2020 Aug;158:104844
pubmed: 32438035
Cancer Cell. 2018 May 14;33(5):905-921.e5
pubmed: 29763624
Br J Cancer. 2009 Jan 27;100(2):405-11
pubmed: 19165203
Immunity. 2014 May 15;40(5):635-7
pubmed: 24837098
Nat Commun. 2018 Jan 2;9(1):38
pubmed: 29295993
J Biol Chem. 1996 Jun 21;271(25):14883-90
pubmed: 8662767
Int J Mol Sci. 2020 Jul 31;21(15):
pubmed: 32752017
Genomics. 1996 May 1;33(3):480-7
pubmed: 8661007
Anticancer Res. 2002 Sep-Oct;22(5):2555-7
pubmed: 12529963
Oncogene. 2010 Dec 16;29(50):6509-21
pubmed: 20890298
Expert Opin Investig Drugs. 2018 Dec;27(12):963-970
pubmed: 30426805
Cancer Chemother Pharmacol. 2018 Jan;81(1):141-153
pubmed: 29149426
Oncogene. 2013 Oct 31;32(44):5210-9
pubmed: 23208505
Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12452-12461
pubmed: 31152137
Cell Rep. 2017 Dec 26;21(13):3819-3832
pubmed: 29281830
Melanoma Res. 2015 Oct;25(5):399-405
pubmed: 26237765
Clin Cancer Res. 2001 Nov;7(11):3399-403
pubmed: 11705854
Nat Rev Cancer. 2016 Sep 23;16(10):663-73
pubmed: 27658636
Front Oncol. 2020 Sep 02;10:1462
pubmed: 32983978
Cancer Res. 2000 Dec 15;60(24):7075-83
pubmed: 11156414
Cancer Res. 2015 May 1;75(9):1782-8
pubmed: 25855379
Cell. 2017 Oct 5;171(2):358-371.e9
pubmed: 28985563
Science. 2016 Jan 1;351(6268):43-8
pubmed: 26449471
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1185-1193
pubmed: 32396749
Am J Clin Oncol. 2020 Jul;43(7):484-490
pubmed: 32251122
Breast Cancer Res. 2017 Oct 11;19(1):112
pubmed: 29020998
Cancer Cell. 2015 Mar 9;27(3):317-9
pubmed: 25759015
Front Cell Dev Biol. 2018 Sep 04;6:96
pubmed: 30234109
Sci Rep. 2015 Nov 24;5:16954
pubmed: 26599282
Nature. 2019 Apr;568(7750):127-130
pubmed: 30867591
Cancer Res. 2001 Sep 1;61(17):6394-9
pubmed: 11522632

Auteurs

Geetha Venkateswaran (G)

Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
Interdisciplinary Oncology Program, The University of British Columbia, Vancouver, BC, Canada.

Shoukat Dedhar (S)

Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
Interdisciplinary Oncology Program, The University of British Columbia, Vancouver, BC, Canada.
Department of Biochemistry and Molecular Biology, The University of British Columbia, Vancouver, BC, Canada.

Classifications MeSH